Drug Discovery Initiative (DDI) supports researchers testing novel or repurposed NF therapies and validating therapeutic targets to generate preliminary data and advance drug discovery.
Accelerating Drug Discovery for FTD supports investigators developing small molecule and biologic drugs through lead optimization and animal-model testing to advance disease-modifying treatments for FTD.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
Cancer Research UK's CDD supports the development of novel cancer agents from preclinical stages to early clinical trials with expert resources, not monetary funding.
Young Investigator Award (YIA) supports graduate students and postdoctoral fellows pursuing basic and translational neurofibromatosis research to build independent careers and generate data for larger grants.
ADDF-Harrington Scholar Program supports academic researchers with drug-development funding and expert guidance to advance novel medicines that treat, prevent, slow, or reverse Alzheimer’s and related dementias.